OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Evaluating the innovative potential of the global antibacterial pipeline
Ursula Theuretzbacher
Clinical Microbiology and Infection (2023)
Open Access | Times Cited: 8
Ursula Theuretzbacher
Clinical Microbiology and Infection (2023)
Open Access | Times Cited: 8
Showing 8 citing articles:
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
Ramanan Laxminarayan, Isabella Impalli, Radha Rangarajan, et al.
The Lancet (2024) Vol. 403, Iss. 10443, pp. 2534-2550
Closed Access | Times Cited: 44
Ramanan Laxminarayan, Isabella Impalli, Radha Rangarajan, et al.
The Lancet (2024) Vol. 403, Iss. 10443, pp. 2534-2550
Closed Access | Times Cited: 44
Iron‐doped nanozymes with spontaneous peroxidase‐mimic activity as a promising antibacterial therapy for bacterial keratitis
Xiwen Geng, Nan Zhang, Zhanrong Li, et al.
Smart Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 7
Xiwen Geng, Nan Zhang, Zhanrong Li, et al.
Smart Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 7
Global health perspectives on antibacterial drug discovery and the preclinical pipeline
Ursula Theuretzbacher, Ravindra P. Jumde, Alan J. Hennessy, et al.
Nature Reviews Microbiology (2025)
Closed Access
Ursula Theuretzbacher, Ravindra P. Jumde, Alan J. Hennessy, et al.
Nature Reviews Microbiology (2025)
Closed Access
Relative inhibitory activities of newly developed diazabicyclooctanes, boronic acid derivatives, and penicillin-based sulfone β-lactamase inhibitors against broad-spectrum AmpC β-lactamases
Christophe Le Terrier, Patrik Mlynárčik, Mustafa Sadek, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access | Times Cited: 4
Christophe Le Terrier, Patrik Mlynárčik, Mustafa Sadek, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access | Times Cited: 4
Exploring PLGA-OH-CATH30 Microspheres for Oral Therapy of Escherichia coli-Induced Enteritis
Xiaoqian Jiao, Bin Liu, Xufeng Dong, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 86-86
Open Access | Times Cited: 2
Xiaoqian Jiao, Bin Liu, Xufeng Dong, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 86-86
Open Access | Times Cited: 2
New antibiotics to combat One Health AMR
Abiodun D. Ogunniyi, Henrietta Venter, Mark A. T. Blaskovich
Microbiology Australia (2024) Vol. 45, Iss. 2, pp. 74-78
Open Access | Times Cited: 2
Abiodun D. Ogunniyi, Henrietta Venter, Mark A. T. Blaskovich
Microbiology Australia (2024) Vol. 45, Iss. 2, pp. 74-78
Open Access | Times Cited: 2
Challenges and strategies for addressing antibacterial drug resistance in LMICs
Ursula Theuretzbacher
Nature Reviews Microbiology (2024) Vol. 22, Iss. 10, pp. 591-592
Closed Access | Times Cited: 2
Ursula Theuretzbacher
Nature Reviews Microbiology (2024) Vol. 22, Iss. 10, pp. 591-592
Closed Access | Times Cited: 2
Volume 45 Number 2
Andrea R. McWhorter, Darren J. Trott, Mark A. Schembri, et al.
Microbiology Australia (2024) Vol. 45, Iss. 2, pp. 45-108
Open Access
Andrea R. McWhorter, Darren J. Trott, Mark A. Schembri, et al.
Microbiology Australia (2024) Vol. 45, Iss. 2, pp. 45-108
Open Access
